Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between Sufentanil and Remifentanil as General Anesthetic Adjuvant

NCT03868111 is registered in ClinicalTrials.gov with Kangbuk Samsung Hospital as lead sponsor.

NCT NCT03868111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03868111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between Sufentanil and Remifentanil as General Anesthetic Adjuvant
Lead sponsor
Kangbuk Samsung Hospital
Phase
Not applicable
Overall status
Completed
Start date
November 4, 2019
Completion date
January 12, 2020
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia